155 related articles for article (PubMed ID: 27189198)
1. Chemosensitivity enhancement toward arsenic trioxide by inhibition of histone deacetylase in NB4 cell line.
Li X; Guan X; Li F; Chen Y; Li N
J Int Med Res; 2016 Aug; 44(4):882-92. PubMed ID: 27189198
[TBL] [Abstract][Full Text] [Related]
2. Vorinostat enhances chemosensitivity to arsenic trioxide in K562 cell line.
Li N; Guan X; Li F; Li X; Chen Y
PeerJ; 2015; 3():e962. PubMed ID: 26038719
[TBL] [Abstract][Full Text] [Related]
3. [Apoptosis of NB4 cells induced by Tanshinone II A combined with arsenic trioxide].
Zhang G; Yang YM; Meng WT; Zhou J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):57-61. PubMed ID: 20369471
[TBL] [Abstract][Full Text] [Related]
4. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
5. [Changes of activity and expression of protein phosphatase type 2A during the apoptosis of NB4 and MR2 cells induced by arsenic trioxide].
Xu XH; Ouyang J; Xie PH; Chen JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1021-5. PubMed ID: 18928587
[TBL] [Abstract][Full Text] [Related]
6. [Effects of cucurmosin combined with common chemotherapeutics on proliferation and apoptosis of NB4 cells].
Xle JM; Liu M; Liu TB; Chen MH; Yang AQ; Yang P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1327-31. PubMed ID: 23257426
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells.
Freitas RA; Silva dos Santos GA; Gimenes Teixeira HL; Scheucher PS; Lucena-Araujo AR; Lima AS; Abreu e Lima RS; Garcia AB; Jordão AA; Falcão RP; Vannucchi H; Rego EM
Leuk Res; 2009 Jul; 33(7):958-63. PubMed ID: 19013639
[TBL] [Abstract][Full Text] [Related]
8. Carnosic Acid-combined Arsenic Trioxide Antileukaemia Cells in the Establishment of NB4/SCID Mouse Model.
Hao L; Ran W; Xiang-Xin L; Lu-Qun W; Xiao-Ning Y
Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):259-66. PubMed ID: 26998898
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A.
Iriyama N; Yuan B; Hatta Y; Horikoshi A; Yoshino Y; Toyoda H; Aizawa S; Takeuchi J
Oncol Rep; 2012 Nov; 28(5):1875-82. PubMed ID: 22940758
[TBL] [Abstract][Full Text] [Related]
10. Potent reducing effects of vitamin D3 on the frequency of apoptosis induced by arsenic trioxide in NB4 cell line.
Mozdarani H; Asghari F
Arch Iran Med; 2010 Jan; 13(1):26-33. PubMed ID: 20039766
[TBL] [Abstract][Full Text] [Related]
11. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
12. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide.
Chien CW; Yao JH; Chang SY; Lee PC; Lee TC
Toxicol Appl Pharmacol; 2011 Nov; 257(1):59-66. PubMed ID: 21889949
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with 5-amino-4-imidazolecarboxamide riboside and arsenic trioxide in acute myeloid leukemia cells involving AMPK/TSC2/mTOR pathway.
Chen L; Han F; Qu H; Yan H; Ren L; Yang S
Pharmazie; 2013 Feb; 68(2):117-23. PubMed ID: 23469683
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
[TBL] [Abstract][Full Text] [Related]
15. [Homoharringtonine combined arsenic trioxide induced apoptosis in human multiple myeloma cell line RPMI 8226: an experimental research].
Zhou XJ; Zhou YH; Chen XH; Qian WB
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):834-9. PubMed ID: 23980369
[TBL] [Abstract][Full Text] [Related]
16. Involvement of protein phosphatase 2A in arsenic trioxide-induced differentiation and apoptosis of NB4 cells.
Ouyang J; Xu XH; Chen JH; Xie PH; Xia YQ
Methods Find Exp Clin Pharmacol; 2008; 30(6):411-9. PubMed ID: 18850042
[TBL] [Abstract][Full Text] [Related]
17. Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters.
Xargay-Torrent S; López-Guerra M; Saborit-Villarroya I; Rosich L; Campo E; Roué G; Colomer D
Clin Cancer Res; 2011 Jun; 17(12):3956-68. PubMed ID: 21652541
[TBL] [Abstract][Full Text] [Related]
18. The histone deacetylase inhibitor vorinostat selectively sensitizes fibrosarcoma cells to chemotherapy.
Sampson ER; Amin V; Schwarz EM; O'Keefe RJ; Rosier RN
J Orthop Res; 2011 Apr; 29(4):623-32. PubMed ID: 20957741
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells.
Lunghi P; Tabilio A; Lo-Coco F; Pelicci PG; Bonati A
Leukemia; 2005 Feb; 19(2):234-44. PubMed ID: 15538402
[TBL] [Abstract][Full Text] [Related]
20. Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
Carbone C; Di Gennaro E; Piro G; Milone MR; Pucci B; Caraglia M; Budillon A
Amino Acids; 2017 Mar; 49(3):517-528. PubMed ID: 27761756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
